{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:37:51Z","timestamp":1793047071639,"version":"4.5.0"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001719"],"award-info":[{"award-number":["82001719"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52073060"],"award-info":[{"award-number":["52073060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61927805"],"award-info":[{"award-number":["61927805"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["T2225003"],"award-info":[{"award-number":["T2225003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82330055"],"award-info":[{"award-number":["82330055"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930043"],"award-info":[{"award-number":["81930043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20380"],"award-info":[{"award-number":["U24A20380"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019349","name":"Nanjing Medical Science and Technique Development Foundation","doi-asserted-by":"publisher","award":["ZKX21019"],"award-info":[{"award-number":["ZKX21019"]}],"id":[{"id":"10.13039\/501100019349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFA0710800"],"award-info":[{"award-number":["2020YFA0710800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFA0908200"],"award-info":[{"award-number":["2020YFA0908200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019155","name":"Nanjing Drum Tower Hospital","doi-asserted-by":"publisher","award":["2022-LCYI-ZD-01"],"award-info":[{"award-number":["2022-LCYI-ZD-01"]}],"id":[{"id":"10.13039\/501100019155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BE2018707"],"award-info":[{"award-number":["BE2018707"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jaut.2026.103620","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:42:51Z","timestamp":1788540171000},"page":"103620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PTX3 in rheumatic and autoimmune diseases: Pathogenesis, biomarker potential, and therapeutic implications"],"prefix":"10.1016","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0351-9663","authenticated-orcid":false,"given":"Honghao","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuting","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jaut.2026.103620_bib1","article-title":"Association between blood Pentraxin\u20103 concentrations and rheumatic diseases: a systematic review and meta\u2010analysis","volume":"54","author":"Di Lorenzo","year":"2024","journal-title":"Eur. J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.jaut.2026.103620_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102584","article-title":"Pentraxin 3: a promising therapeutic target for autoimmune diseases","volume":"19","author":"Wu","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"10.1016\/j.jaut.2026.103620_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.arcmed.2016.05.006","article-title":"Association of pentraxin 3 with autoimmune diseases: a systematic review and meta-analysis","volume":"47","author":"Huang","year":"2016","journal-title":"Arch. Med. Res."},{"issue":"2","key":"10.1016\/j.jaut.2026.103620_bib4","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1152\/physrev.00016.2017","article-title":"PTX3, a humoral pattern recognition molecule, in innate immunity, tissue repair, and cancer","volume":"98","author":"Garlanda","year":"2018","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.jaut.2026.103620_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.imlet.2014.04.012","article-title":"The yin-yang of long pentraxin PTX3 in inflammation and immunity","volume":"161","author":"Daigo","year":"2014","journal-title":"Immunol. Lett."},{"issue":"10","key":"10.1016\/j.jaut.2026.103620_bib6","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood.V84.10.3483.3483","article-title":"Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes","volume":"84","author":"Alles","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2026.103620_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2012.00378","article-title":"Host-protective effect of circulating pentraxin 3 (PTX3) and complex formation with neutrophil extracellular traps","volume":"3","author":"Daigo","year":"2012","journal-title":"Front. Immunol."},{"issue":"21","key":"10.1016\/j.jaut.2026.103620_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113487","article-title":"The effects of silencing PTX3 on the proteome of human endothelial cells","volume":"23","author":"Banfi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2026.103620_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1426869","article-title":"PTX3 is expressed in terminal lymphatics and shapes their organization and function","volume":"15","author":"Doni","year":"2024","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.jaut.2026.103620_bib10","doi-asserted-by":"crossref","first-page":"8303","DOI":"10.4049\/jimmunol.175.12.8303","article-title":"TNF\u03b1-Induced long Pentraxin PTX3 expression in human lung epithelial cells via JNK","volume":"175","author":"Han","year":"2005","journal-title":"J. Immunol."},{"issue":"13","key":"10.1016\/j.jaut.2026.103620_bib11","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1182\/blood.V96.13.4300","article-title":"The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells","volume":"96","author":"Rovere","year":"2000","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jaut.2026.103620_bib12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/CIRCULATIONAHA.108.806547","article-title":"Deficiency of the long Pentraxin PTX3 promotes vascular inflammation and atherosclerosis","volume":"120","author":"Norata","year":"2009","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.jaut.2026.103620_bib13","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/CIRCULATIONAHA.107.749234","article-title":"Cardioprotective function of the long Pentraxin PTX3 in acute myocardial infarction","volume":"117","author":"Salio","year":"2008","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.jaut.2026.103620_bib14","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.7150\/ijms.54787","article-title":"Perspectives on long pentraxin 3 and rheumatoid arthritis: several potential breakthrough points relying on study foundation of the past","volume":"18","author":"Qiu","year":"2021","journal-title":"Int. J. Med. Sci."},{"issue":"52","key":"10.1016\/j.jaut.2026.103620_bib15","doi-asserted-by":"crossref","first-page":"32817","DOI":"10.1074\/jbc.272.52.32817","article-title":"Multimer formation and ligand recognition by the long Pentraxin PTX3","volume":"272","author":"Bottazzi","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.jaut.2026.103620_bib16","doi-asserted-by":"crossref","first-page":"10147","DOI":"10.1074\/jbc.M708535200","article-title":"Structural characterization of PTX3 disulfide bond network and its multimeric status in cumulus matrix organization","volume":"283","author":"Inforzato","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2026.103620_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.139207","article-title":"Disulfide bonds-driven assembly and structural complexity of PTX3: high-resolution structures insights into multimeric architecture","volume":"292","author":"Guo","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"38","key":"10.1016\/j.jaut.2026.103620_bib18","doi-asserted-by":"crossref","first-page":"11540","DOI":"10.1021\/bi0607453","article-title":"Structure and function of the long Pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation","volume":"45","author":"Inforzato","year":"2006","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.jaut.2026.103620_bib19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/immu.200310022","article-title":"Biochemical and functional characterization of the interaction between pentraxin 3 and C1q","volume":"33","author":"Nauta","year":"2003","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.jaut.2026.103620_bib20","doi-asserted-by":"crossref","first-page":"8433","DOI":"10.4049\/jimmunol.181.12.8433","article-title":"Binding of the long Pentraxin PTX3 to factor H: interacting domains and function in the regulation of complement activation","volume":"181","author":"Deban","year":"2008","journal-title":"J. Immunol."},{"issue":"32","key":"10.1016\/j.jaut.2026.103620_bib21","doi-asserted-by":"crossref","first-page":"22605","DOI":"10.1074\/jbc.M601023200","article-title":"Identification of an antiangiogenic FGF2-binding site in the N terminus of the soluble pattern recognition receptor PTX3","volume":"281","author":"Camozzi","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.jaut.2026.103620_bib22","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1084\/jem.20141268","article-title":"An acidic microenvironment sets the humoral pattern recognition molecule PTX3 in a tissue repair mode","volume":"212","author":"Doni","year":"2015","journal-title":"J. Exp. Med."},{"issue":"41","key":"10.1016\/j.jaut.2026.103620_bib23","doi-asserted-by":"crossref","first-page":"30161","DOI":"10.1074\/jbc.M703738200","article-title":"PTX3 interacts with Inter-\u03b1-trypsin inhibitor","volume":"282","author":"Scarchilli","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jaut.2026.103620_bib24","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1365-2249.2000.01110.x","article-title":"Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA)","volume":"119","author":"Luchetti","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2026.103620_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103182","article-title":"Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset still's disease","volume":"144","author":"Zhu","year":"2024","journal-title":"J. Autoimmun."},{"issue":"10","key":"10.1016\/j.jaut.2026.103620_bib26","doi-asserted-by":"crossref","first-page":"7741","DOI":"10.18632\/oncotarget.3482","article-title":"PTX3 gene activation in EGF-induced head and neck cancer cell metastasis","volume":"6","author":"Chang","year":"2015","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.jaut.2026.103620_bib27","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.4049\/jimmunol.2101105","article-title":"STAT3 activates the pentraxin 3 gene in chronic lymphocytic leukemia cells","volume":"208","author":"Rozovski","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2026.103620_bib28","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1333215","article-title":"Epigenetic regulation of the extrinsic oncosuppressor PTX3 gene in inflammation and cancer","author":"Rubino","year":"2017","journal-title":"OncoImmunology"},{"issue":"8","key":"10.1016\/j.jaut.2026.103620_bib29","first-page":"712","article-title":"Pentraxin 3 (PTX3) promoter methylation associated with PTX3 plasma levels and neutrophil to lymphocyte ratio in coronary artery disease","volume":"13","author":"Guo","year":"2016","journal-title":"J. Geriatr. Cardiol."},{"issue":"1","key":"10.1016\/j.jaut.2026.103620_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10616-020-00446-z","article-title":"MiR-29b-3p aggravates cardiac hypoxia\/reoxygenation injury via targeting PTX3","volume":"73","author":"He","year":"2021","journal-title":"Cytotechnology"},{"issue":"9","key":"10.1016\/j.jaut.2026.103620_bib31","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1136\/ard-2023-225343","article-title":"NAT10 promotes synovial aggression by increasing the stability and translation of N4-acetylated PTX3 mRNA in rheumatoid arthritis","volume":"83","author":"Liu","year":"2024","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.jaut.2026.103620_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12016-015-8476-9","article-title":"PTX3, Anti-PTX3, and Anti-C1q autoantibodies in lupus glomerulonephritis","volume":"49","author":"Bassi","year":"2015","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2026.103620_bib33","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/art.21669","article-title":"Abundance of the long pentraxin PTX3 at sites of leukocytoclastic lesions in patients with small\u2010vessel vasculitis","volume":"54","author":"van Rossum","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.jaut.2026.103620_bib34","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1002\/art.20370","article-title":"The prototypic tissue pentraxin PTX3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages","volume":"50","author":"van Rossum","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.jaut.2026.103620_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1361.041","article-title":"Activation, apoptosis, and clearance of neutrophils in Wegener's granulomatosis","volume":"1051","author":"Rossum","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"7","key":"10.1016\/j.jaut.2026.103620_bib36","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1242\/dev.01056","article-title":"PTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization","volume":"131","author":"Salustri","year":"2004","journal-title":"Development"},{"issue":"4","key":"10.1016\/j.jaut.2026.103620_bib37","doi-asserted-by":"crossref","first-page":"372","DOI":"10.5551\/jat.26740","article-title":"Deficiency of long Pentraxin PTX3 promoted Neointimal Hyperplasia after vascular injury","volume":"22","author":"Ishino","year":"2015","journal-title":"J. Atherosclerosis Thromb."},{"issue":"9","key":"10.1016\/j.jaut.2026.103620_bib38","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/ard.2009.117804","article-title":"IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus","volume":"69","author":"Bassi","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.jaut.2026.103620_bib39","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/annrheumdis-2020-218460","article-title":"Novel autoantibodies identified in ACPA-negative rheumatoid arthritis","volume":"80","author":"Li","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.jaut.2026.103620_bib40","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/0886022X.2017.1308258","article-title":"Anti-pentraxin 3 auto-antibodies might be protective in lupus nephritis: a large cohort study","volume":"39","author":"Yuan","year":"2017","journal-title":"Ren. Fail."},{"issue":"1","key":"10.1016\/j.jaut.2026.103620_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147091","article-title":"Detection of Anti-Pentraxin-3 autoantibodies in ANCA-associated vasculitis","volume":"11","author":"Simon","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2026.103620_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102725","article-title":"IgG anti-Pentraxin 3 antibodies are a novel biomarker of ANCA-associated vasculitis and better identify patients with eosinophilic granulomatosis with polyangiitis","volume":"124","author":"Padoan","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2026.103620_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.626343","article-title":"Anti-Pentraxin antibodies in autoimmune diseases: bystanders or pathophysiological actors?","volume":"11","author":"Brilland","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.jaut.2026.103620_bib44","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1211161","article-title":"Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation","volume":"370","author":"Cunha","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2026.103620_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.666198","article-title":"The long pentraxin PTX3 controls Klebsiella Pneumoniae severe infection","volume":"12","author":"Asgari","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2026.103620_bib46","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78601","article-title":"Regulation of inflammation and protection against invasive pneumococcal infection by the long pentraxin PTX3","volume":"12","author":"Porte","year":"2023","journal-title":"eLife"},{"issue":"343","key":"10.1016\/j.jaut.2026.103620_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2005522","article-title":"Protective effect of the long pentraxin PTX3 against histone-mediated endothelial cell cytotoxicity in sepsis","volume":"7","author":"Daigo","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jaut.2026.103620_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.676702","article-title":"PTX3 regulation of inflammation, hemostatic response, tissue repair, and resolution of fibrosis favors a role in limiting idiopathic pulmonary fibrosis","volume":"12","author":"Doni","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2026.103620_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102336","article-title":"Complement C1q synergizes with PTX3 in promoting NLRP3 inflammasome over-activation and pyroptosis in rheumatoid arthritis","volume":"106","author":"Wu","year":"2020","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.jaut.2026.103620_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020118","article-title":"Lack of the long pentraxin PTX3 promotes autoimmune lung disease but not glomerulonephritis in murine systemic lupus erythematosus","volume":"6","author":"Lech","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2026.103620_bib51","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3389\/fimmu.2019.01135","article-title":"PTX3 intercepts vascular inflammation in systemic immune-mediated diseases","volume":"10","author":"Ramirez","year":"2019","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.jaut.2026.103620_bib52","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-155-7-201110040-00005","article-title":"Pentraxin-3 as a marker of disease activity in takayasu arteritis","volume":"155","author":"Dagna","year":"2011","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.jaut.2026.103620_bib53","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-014-0479-z","article-title":"Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis","volume":"16","author":"Tombetti","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.jaut.2026.103620_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245612","article-title":"Pentraxin 3 is more accurate than C-reactive protein for Takayasu arteritis activity assessment: a systematic review and meta-analysis","volume":"16","author":"Wen","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2026.103620_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109794","article-title":"Exploration of molecular signatures associated with different clinical features of Takayasu arteritis based on a prospective cohort study","volume":"256","author":"Kong","year":"2023","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2026.103620_bib56","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/art.33411","article-title":"Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: relevance for recent optic nerve ischemia","volume":"64","author":"Baldini","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.jaut.2026.103620_bib57","first-page":"23","article-title":"Imbalance between angiogenic and anti-angiogenic factors in sera from patients with large-vessel vasculitis","volume":"38","author":"Pulsatelli","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"issue":"12","key":"10.1016\/j.jaut.2026.103620_bib58","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1002\/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6","article-title":"PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation","volume":"44","author":"Fazzini","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.jaut.2026.103620_bib59","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/03009742.2022.2045790","article-title":"Pentraxin-3 - a potential biomarker in ANCA-associated vasculitis","volume":"52","author":"Jonasdottir","year":"2023","journal-title":"Scand. J. Rheumatol."},{"issue":"2","key":"10.1016\/j.jaut.2026.103620_bib60","first-page":"79","article-title":"Plasma pentraxin 3 (PTX3) level is associated with the disease activity of microscopic polyangiitis (MPA)","volume":"59","author":"Yamaguchi","year":"2017","journal-title":"Nihon Jinzo Gakkai Shi."},{"issue":"9","key":"10.1016\/j.jaut.2026.103620_bib61","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00109-020-01955-2","article-title":"Microparticles expressing myeloperoxidase as potential biomarkers in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV)","volume":"98","author":"Manojlovic","year":"2020","journal-title":"J. Mol. Med."},{"issue":"2","key":"10.1016\/j.jaut.2026.103620_bib62","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00431-013-2150-0","article-title":"Pentraxin 3 as a novel early biomarker for the prediction of Henoch-Sch\u00f6nlein purpura nephritis in children","volume":"173","author":"Ge","year":"2014","journal-title":"Eur. J. Pediatr."},{"issue":"6","key":"10.1016\/j.jaut.2026.103620_bib63","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00467-014-3026-x","article-title":"Could serum pentraxin 3 levels and IgM deposition in skin biopsies predict subsequent renal involvement in children with Henoch\u2013Sch\u00f6nlein purpura?","volume":"30","author":"Y\u00fcksel","year":"2014","journal-title":"Pediatr. Nephrol."},{"issue":"1","key":"10.1016\/j.jaut.2026.103620_bib64","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae395","article-title":"Urine complement-related proteins in IgA nephropathy and IgA vasculitis nephritis, possible biomarkers of disease activity","volume":"18","author":"Nurmi","year":"2024","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.jaut.2026.103620_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.624802","article-title":"Increased pentraxin 3 levels correlate with IVIG responsiveness and coronary artery aneurysm formation in Kawasaki disease","volume":"12","author":"Kitoh","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2026.103620_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2020.00295","article-title":"Elevated levels of pentraxin 3 correlate with neutrophilia and coronary artery dilation during acute Kawasaki disease","volume":"8","author":"Ching","year":"2020","journal-title":"Front. Pediatr."},{"issue":"16","key":"10.1016\/j.jaut.2026.103620_bib67","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.2217\/bmm-2019-0161","article-title":"Circulating Pentraxin-3 levels in patients with systemic lupus erythematosus: a meta-analysis","volume":"13","author":"Wu","year":"2019","journal-title":"Biomarkers Med."},{"key":"10.1016\/j.jaut.2026.103620_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/354014","article-title":"Pentraxin 3 plasma levels and disease activity in systemic lupus erythematosus","volume":"2015","author":"Assandri","year":"2015","journal-title":"Autoimmune Dis."},{"key":"10.1016\/j.jaut.2026.103620_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117592","article-title":"The pentraxin family in autoimmune disease","volume":"551","author":"Li","year":"2023","journal-title":"Clin. Chim. Acta"},{"issue":"10","key":"10.1016\/j.jaut.2026.103620_bib70","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1177\/0961203317699286","article-title":"Pentraxin-3 levels are associated with vasculitis and disease activity in childhood-onset systemic lupus erythematosus","volume":"26","author":"Sahin","year":"2017","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.jaut.2026.103620_bib71","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1177\/09612033231175627","article-title":"Serum pentraxin 3 in systemic lupus erythematosus: a potential indicator of cutaneous disease activity","volume":"32","author":"Ismail","year":"2023","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.jaut.2026.103620_bib72","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002520","article-title":"Pentraxin 3 is closely associated with tubulointerstitial injury in Lupus nephritis","volume":"95","author":"Pang","year":"2016","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.jaut.2026.103620_bib73","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11418-023-01777-9","article-title":"Protopanaxadiol improves lupus nephritis by regulating the PTX3\/MAPK\/ERK1\/2 pathway","volume":"78","author":"Li","year":"2024","journal-title":"J. Nat. Med."},{"issue":"1","key":"10.1016\/j.jaut.2026.103620_bib74","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/cei.12957","article-title":"Interferon-\u03b1 coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro","volume":"189","author":"Wirestam","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2026.103620_bib75","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaut.2016.07.002","article-title":"Immunization with pentraxin 3 (PTX3) leads to anti-PTX3 antibody production and delayed lupus-like nephritis in NZB\/NZW F1 mice","volume":"74","author":"Gatto","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2026.103620_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102443","article-title":"Immunization with Pentraxin3 prevents transition from subclinical to clinical lupus nephritis in lupus-prone mice: insights from renal ultrastructural findings","volume":"111","author":"Gatto","year":"2020","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.jaut.2026.103620_bib77","doi-asserted-by":"crossref","DOI":"10.1080\/08916934.2025.2579832","article-title":"Autoantibodies against pentraxin-3 in systemic lupus erythematosus: mapping of reactivity to linear epitopes and associations with disease variables","volume":"58","author":"Karlsson","year":"2025","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2026.103620_bib78","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cca.2018.01.035","article-title":"Acute phase reactant, Pentraxin 3, as a novel marker for the diagnosis of rheumatoid arthritis","volume":"480","author":"Sharma","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.jaut.2026.103620_bib79","first-page":"419","article-title":"Elevated levels of neopterin and pentraxin 3 in patients with rheumatoid arthritis","volume":"42","author":"Ekin","year":"2021","journal-title":"Horm. Mol. Biol. Clin. Invest."},{"issue":"1","key":"10.1016\/j.jaut.2026.103620_bib80","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5114\/aoms.2017.69726","article-title":"Is pentraxin 3 level an effective biomarker in disease activity in patients with rheumatoid arthritis?","volume":"16","author":"Balbaloglu","year":"2020","journal-title":"Arch. Med. Sci."},{"issue":"27","key":"10.1016\/j.jaut.2026.103620_bib81","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.2174\/1381612828666220614155037","article-title":"Increased circulating pentraxin 3 levels in patients with rheumatoid arthritis: a meta-analysis","volume":"28","author":"Guan","year":"2022","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jaut.2026.103620_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.686795","article-title":"Circulating and synovial Pentraxin-3 (PTX3) expression levels correlate with Rheumatoid arthritis severity and tissue infiltration independently of conventional treatments response","volume":"12","author":"Boutet","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2026.103620_bib83","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/s10165-012-0630-0","article-title":"Serum amyloid A (SAA) induces pentraxin 3 (PTX3) production in rheumatoid synoviocytes","volume":"23","author":"Satomura","year":"2013","journal-title":"Mod. Rheumatol."},{"issue":"1","key":"10.1016\/j.jaut.2026.103620_bib84","first-page":"43","article-title":"Geranylgeranyl-pyrophosphate regulates secretion of pentraxin 3 and monocyte chemoattractant protein-1 from rheumatoid fibroblast-like synoviocytes in distinct manners","volume":"29","author":"Yokota","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.jaut.2026.103620_bib85","doi-asserted-by":"crossref","DOI":"10.1111\/1756-185X.14899","article-title":"Successful treatment of anti-PTX3 positive seronegative rheumatoid arthritis with upadacitinib","volume":"27","author":"Xu","year":"2024","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"10.1016\/j.jaut.2026.103620_bib86","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/03009742.2016.1244288","article-title":"Pentraxin 3 in serum and synovial fluid of patients with rheumatoid arthritis with and without autoantibodies","volume":"46","author":"Weitoft","year":"2017","journal-title":"Scand. J. Rheumatol."},{"issue":"4","key":"10.1016\/j.jaut.2026.103620_bib87","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1093\/rheumatology\/keae529","article-title":"Anti-pentraxin 3 antibodies and residual disease activity in rheumatoid arthritis","volume":"64","author":"Salvato","year":"2025","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.jaut.2026.103620_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169830","article-title":"Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis","volume":"12","author":"Deyab","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2026.103620_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110628","article-title":"Pentraxin 3 inhibits fibroblast growth factor 2 induced osteoclastogenesis in rheumatoid arthritis","volume":"131","author":"Zhao","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jaut.2026.103620_bib90","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijcard.2022.08.058","article-title":"Biomarkers in Takayasu arteritis","volume":"371","author":"Wen","year":"2023","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.jaut.2026.103620_bib91","first-page":"137","article-title":"Levels of pentraxin 3 and relationship with disease activity in patients with ankylosing spondylitis","volume":"39","author":"Deniz","year":"2014","journal-title":"Acta. Reumatol. Port."},{"issue":"1","key":"10.1016\/j.jaut.2026.103620_bib92","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/1354750X.2016.1278265","article-title":"Plasma levels of pentraxin 3 in patients with spondyloarthritis","volume":"23","author":"Nisihara","year":"2018","journal-title":"Biomarkers"},{"issue":"1","key":"10.1016\/j.jaut.2026.103620_bib93","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7243399","article-title":"The relationship between plasma Pentraxin 3 and serum amyloid P levels and disease activity in ankylosing spondylitis","volume":"2022","author":"\u00d6zdemirel","year":"2022","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.jaut.2026.103620_bib94","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.12659\/MSM.896562","article-title":"Association of genetic variants in pentraxin 3 gene with ankylosing spondylitis","volume":"22","author":"Zhang","year":"2016","journal-title":"Med. Sci. Monit."},{"issue":"5","key":"10.1016\/j.jaut.2026.103620_bib95","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/stem.3332","article-title":"SMAD-specific E3 ubiquitin ligase 2 promotes angiogenesis by facilitating PTX3 degradation in MSCs from patients with ankylosing spondylitis","volume":"39","author":"Ma","year":"2021","journal-title":"Stem Cell."},{"issue":"3","key":"10.1016\/j.jaut.2026.103620_bib96","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2174\/1573397117666210114110823","article-title":"Concomitant diagnosis of fibromyalgia and ankylosing spondylitis: relation to clinical features and plasma pentraxin -3 level","volume":"17","author":"Baraka","year":"2021","journal-title":"Curr. Rheumatol. Rev."},{"issue":"7","key":"10.1016\/j.jaut.2026.103620_bib97","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1007\/s10620-007-0075-z","article-title":"Increased expression of long pentraxin PTX3 in inflammatory bowel diseases","volume":"53","author":"Kato","year":"2008","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jaut.2026.103620_bib98","doi-asserted-by":"crossref","DOI":"10.1097\/MCG.0000000000002236","article-title":"Role of sepsis markers as potential biomarkers for inflammatory bowel disease","author":"Ishida","year":"2025","journal-title":"J. Clin. Gastroenterol."},{"issue":"1","key":"10.1016\/j.jaut.2026.103620_bib99","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3892\/mmr.2015.3451","article-title":"Serum pentraxin 3 is a novel marker in Crohn's disease","volume":"12","author":"Chen","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"10","key":"10.1016\/j.jaut.2026.103620_bib100","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3390\/biom13101448","article-title":"Usefulness of Proguanylin, pentraxin 3 and S100A12 serum concentrations in diagnosis and monitoring the disease activity in Crohn's disease","volume":"13","author":"Ka\u0142u\u017cna","year":"2023","journal-title":"Biomolecules"},{"issue":"13","key":"10.1016\/j.jaut.2026.103620_bib101","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.3390\/jcm12134339","article-title":"Circulating profiles of Serum Proguanylin, S100A12 protein and pentraxin 3 as diagnostic markers of ulcerative colitis","volume":"12","author":"Ka\u0142u\u017cna","year":"2023","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.jaut.2026.103620_bib102","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1440-1827.2011.02651.x","article-title":"Long pentraxin 3 (PTX3) expression and release by neutrophils in vitro and in ulcerative colitis","volume":"61","author":"Savchenko","year":"2011","journal-title":"Pathol. Int."},{"issue":"2","key":"10.1016\/j.jaut.2026.103620_bib103","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/00365521.2016.1235224","article-title":"Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications","volume":"52","author":"Muthas","year":"2017","journal-title":"Scand. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.jaut.2026.103620_bib104","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/pin.12794","article-title":"Prediction of steroid demand in the treatment of patients with ulcerative colitis by immunohistochemical analysis of the mucosal microenvironment and immune checkpoint: role of macrophages and regulatory markers in disease severity","volume":"69","author":"Tsuda","year":"2019","journal-title":"Pathol. Int."},{"issue":"9","key":"10.1016\/j.jaut.2026.103620_bib105","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00011-024-01910-8","article-title":"Fibroblast growth factor receptor 4 deficiency in macrophages aggravates experimental colitis by promoting M1-polarization","volume":"73","author":"Shen","year":"2024","journal-title":"Inflamm. Res."},{"issue":"21","key":"10.1016\/j.jaut.2026.103620_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252111544","article-title":"The impact of pentraxin 3 on Crohn's disease phenotype","volume":"25","author":"Kofla-Dlubacz","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.jaut.2026.103620_bib107","doi-asserted-by":"crossref","DOI":"10.1590\/acb370503","article-title":"Histone deacetylase inhibitor givinostat has ameliorative effect in the colitis model","volume":"37","author":"Dibeko\u011flu","year":"2022","journal-title":"Acta Cir. Bras."},{"issue":"1","key":"10.1016\/j.jaut.2026.103620_bib108","doi-asserted-by":"crossref","DOI":"10.1186\/s12906-024-04400-w","article-title":"Effects of Spirulina supplementation in patients with ulcerative colitis: a double-blind, placebo-controlled randomized trial","volume":"24","author":"Moradi","year":"2024","journal-title":"BMC Complement. Med. Ther."},{"issue":"6","key":"10.1016\/j.jaut.2026.103620_bib109","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/medicina61061033","article-title":"Indoximod Attenuates inflammatory responses in acetic acid-induced acute colitis by modulating toll-like receptor 4 (TLR4) signaling and proinflammatory cytokines in rats","volume":"61","author":"Ercan","year":"2025","journal-title":"Medicina"},{"issue":"10","key":"10.1016\/j.jaut.2026.103620_bib110","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1111\/ijd.12959","article-title":"Serum levels of alpha-1 acid glycoprotein and pentraxin 3 in patients with Beh\u00e7et's disease and relationship with disease activity","volume":"54","author":"Yazmalar","year":"2015","journal-title":"Int. J. Dermatol."},{"issue":"2","key":"10.1016\/j.jaut.2026.103620_bib111","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5606\/ArchRheumatol.2017.6129","article-title":"Can Pentraxin-3 be a candidate marker in the Follow-Up of the patients with Beh\u00e7et's disease?","volume":"32","author":"Alpaslan","year":"2017","journal-title":"Arch. Rheumatol."},{"issue":"7","key":"10.1016\/j.jaut.2026.103620_bib112","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1080\/09273948.2025.2491565","article-title":"Pentraxin 3 is a novel inflammatory marker of HLA-B27-associated uveitis","volume":"33","author":"Abu El-Asrar","year":"2025","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"2","key":"10.1016\/j.jaut.2026.103620_bib113","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/00015385.2018.1560071","article-title":"The association of inflammatory markers and echocardiographic parameters in Beh\u00e7et's disease","volume":"75","author":"\u00c7al\u0131k","year":"2020","journal-title":"Acta Cardiol."},{"issue":"5","key":"10.1016\/j.jaut.2026.103620_bib114","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3899\/jrheum.080343","article-title":"Increased serum pentraxin 3 in patients with systemic sclerosis","volume":"36","author":"Iwata","year":"2009","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.jaut.2026.103620_bib115","first-page":"102","article-title":"Prediction of organ involvement in systemic sclerosis by serum biomarkers and peripheral endothelial function","volume":"36","author":"Kawashiri","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.jaut.2026.103620_bib116","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/art.38953","article-title":"Elevated levels of pentraxin 3 in systemic sclerosis: associations with vascular manifestations and defective vasculogenesis","volume":"67","author":"Shirai","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.jaut.2026.103620_bib117","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/acr.25180","article-title":"Endothelial biomarkers of systemic sclerosis-associated pulmonary hypertension","volume":"77","author":"Lammi","year":"2025","journal-title":"Arthritis Care Res."},{"issue":"10","key":"10.1016\/j.jaut.2026.103620_bib118","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1593\/neo.09934","article-title":"Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in mice","volume":"11","author":"Margheri","year":"2009","journal-title":"Neoplasia"},{"issue":"8","key":"10.1016\/j.jaut.2026.103620_bib119","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1002\/art.27522","article-title":"Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain\u2013loss of function of pentraxin 3 and matrix metalloproteinase 12","volume":"62","author":"Margheri","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"Si","key":"10.1016\/j.jaut.2026.103620_bib120","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keac433","article-title":"Soluble guanylate cyclase stimulation fosters angiogenesis and blunts myofibroblast-like features of systemic sclerosis endothelial cells","volume":"62","author":"Romano","year":"2023","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.jaut.2026.103620_bib121","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/cei\/uxad063","article-title":"Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity","volume":"214","author":"Fornaro","year":"2023","journal-title":"Clin. Exp. Immunol."},{"issue":"7","key":"10.1016\/j.jaut.2026.103620_bib122","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1177\/1352458512457845","article-title":"Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica","volume":"19","author":"Wang","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jaut.2026.103620_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577385","article-title":"12-months prospective Pentraxin-3 and metabolomic evaluation in multiple sclerosis patients treated with glatiramer acetate","volume":"348","author":"Signoriello","year":"2020","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.jaut.2026.103620_bib124","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-5728(00)00279-4","article-title":"Increased peripheral benzodiazepine binding sites and pentraxin 3 expression in the spinal cord during EAE: relation to inflammatory cytokines and modulation by dexamethasone and rolipram","volume":"109","author":"Agnello","year":"2000","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.jaut.2026.103620_bib125","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/eji.201545950","article-title":"Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease","volume":"46","author":"Ummenthum","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.jaut.2026.103620_bib126","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1210\/jc.2016-3222","article-title":"Duodenal Mucosa of patients with type 1 diabetes shows distinctive inflammatory profile and microbiota","volume":"102","author":"Pellegrini","year":"2017","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"2","key":"10.1016\/j.jaut.2026.103620_bib127","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.diabres.2012.11.020","article-title":"Plasma pentraxin 3 levels are associated with carotid IMT in type 1 diabetic patients","volume":"99","author":"Katakami","year":"2013","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"4","key":"10.1016\/j.jaut.2026.103620_bib128","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/08916930902831464","article-title":"Elevation of plasma levels of the long pentraxin 3 precedes preeclampsia in pregnant patients with type 1 diabetes","volume":"42","author":"Castiglioni","year":"2009","journal-title":"Autoimmunity"},{"issue":"3","key":"10.1016\/j.jaut.2026.103620_bib129","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/gtmb.2015.0238","article-title":"Serum and vitreous pentraxin 3 concentrations in patients with diabetic retinopathy","volume":"20","author":"Zhou","year":"2016","journal-title":"Genet. Test. Mol. Biomark."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841126000983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841126000983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:06:49Z","timestamp":1793045209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841126000983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":129,"alternative-id":["S0896841126000983"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2026.103620","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PTX3 in rheumatic and autoimmune diseases: Pathogenesis, biomarker potential, and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2026.103620","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103620"}}